BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 19493919)

  • 41. Well differentiated papillary mesothelioma of the tunica vaginalis: case report.
    Chys B; De Graeve N; Merckx L
    Acta Chir Belg; 2023 Oct; 123(5):555-558. PubMed ID: 35322759
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Immunohistochemical evidence for mesothelial origin of paratesticular adenomatoid tumour.
    Delahunt B; Eble JN; King D; Bethwaite PB; Nacey JN; Thornton A
    Histopathology; 2000 Feb; 36(2):109-15. PubMed ID: 10672054
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Immunophenotypic analysis of ovarian and testicular Müllerian papillary serous tumors.
    Carano KS; Soslow RA
    Mod Pathol; 1997 May; 10(5):414-20. PubMed ID: 9160304
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Expression of Wilms tumor-1 protein and CD 138 in malignant mesothelioma of the tunica vaginalis.
    Al-Salam S; Hammad FT; Salman MA; AlAshari M
    Pathol Res Pract; 2009; 205(11):797-800. PubMed ID: 19250757
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Serous papillary adenocarcinoma of the tunica vaginalis of the testis: a case report].
    Sugishita K; Kashiwagi A; Nagamori S; Yamashiro K; Sato N
    Nihon Hinyokika Gakkai Zasshi; 2004 Mar; 95(3):626-9. PubMed ID: 15103927
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A case of intratesticular endometrioid papillary cystadenocarcinoma.
    Numakura K; Tsuchiya N; Tsuruta H; Obara T; Saito M; Inoue T; Narita S; Horikawa Y; Satoh S; Nanjyo H; Habuchi T
    Jpn J Clin Oncol; 2011 May; 41(5):674-6. PubMed ID: 21474549
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Clear cell papillary cystadenocarcinoma of the epididymis: a case report and immunohistochemistry of markers for renal cell carcinoma.
    Nozawa T; Konda R; Ohsawa T; Yoshida M; Komatsu M; Iwama T; Fujioka T
    Histol Histopathol; 2013 Mar; 28(3):321-6. PubMed ID: 23348385
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Mesothelial lesions of the paratesticular region.
    Perez-Ordonez B; Srigley JR
    Semin Diagn Pathol; 2000 Nov; 17(4):294-306. PubMed ID: 11202546
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Ovarian clear cell carcinoma with papillary features: a potential mimic of serous tumor of low malignant potential.
    Sangoi AR; Soslow RA; Teng NN; Longacre TA
    Am J Surg Pathol; 2008 Feb; 32(2):269-74. PubMed ID: 18223330
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Malignant mesothelioma of the tunica vaginalis of the testis].
    Borrell Palanca A; Alapont Pérez M; Compañ Quilis A; Gil Salóm M; Günthner S; Chuan Nuez P; Santamaría Meseguer J; Rafie Mazketly W; García Garzon J; Soler Martínez J
    Actas Urol Esp; 1994 Oct; 18(9):899-902. PubMed ID: 7817861
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Significance of combining detection of E-cadherin, carcinoembryonic antigen, and calretinin in cytological differential diagnosis of serous effusion].
    Su XY; Li GD; Liu HB; Jiang LL
    Ai Zheng; 2004 Oct; 23(10):1185-9. PubMed ID: 15473932
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The diagnostic value of thrombomodulin immunolocalization in serous effusions.
    Ascoli V; Scalzo CC; Taccogna S; Nardi F
    Arch Pathol Lab Med; 1995 Dec; 119(12):1136-40. PubMed ID: 7503662
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Novel marker D2-40, combined with calretinin, CEA, and TTF-1: an optimal set of immunodiagnostic markers for pleural mesothelioma.
    Mimura T; Ito A; Sakuma T; Ohbayashi C; Yoshimura M; Tsubota N; Okita Y; Okada M
    Cancer; 2007 Mar; 109(5):933-8. PubMed ID: 17279584
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Lymphohistiocytoid mesothelioma. An often misdiagnosed variant of sarcomatoid malignant mesothelioma.
    Khalidi HS; Medeiros LJ; Battifora H
    Am J Clin Pathol; 2000 May; 113(5):649-54. PubMed ID: 10800396
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Diagnostic utility of calretinin immunohistochemistry in cytologic cell block preparations.
    Wieczorek TJ; Krane JF
    Cancer; 2000 Oct; 90(5):312-9. PubMed ID: 11038429
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Immunohistochemical expression of osteopontin in epithelioid mesotheliomas and reactive mesothelial proliferations.
    Tigrani DY; Weydert JA
    Am J Clin Pathol; 2007 Apr; 127(4):580-4. PubMed ID: 17369133
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Clear cell mesothelioma of the testis with deciduoid areas--a case report.
    Mishra A; Shet T
    Indian J Pathol Microbiol; 2004 Oct; 47(4):544-6. PubMed ID: 16295392
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Mesothelioma of the tunica vaginalis with BerEp4 and LeuM1 expression: identification of cytoplasmic tonofilaments by electron microscopy is a key diagnostic feature.
    Shelton D; Dalal N
    J Clin Pathol; 2012 Oct; 65(10):958-9. PubMed ID: 22593592
    [No Abstract]   [Full Text] [Related]  

  • 59. Differential diagnosis of mesothelial and ovarian cancer cells in ascites by immunocytochemistry using Ber-EP4 and calretinin.
    Sato S; Okamoto S; Ito K; Konno R; Yajima A
    Acta Cytol; 2000; 44(3):485-8. PubMed ID: 10834020
    [No Abstract]   [Full Text] [Related]  

  • 60. Is D2-40 a useful marker for distinguishing malignant mesothelioma from pulmonary adenocarcinoma and benign mesothelial proliferations?
    Deniz H; Kibar Y; Güldür ME; Bakir K
    Pathol Res Pract; 2009; 205(11):749-52. PubMed ID: 19573998
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.